Alternatives to commercially available cell culture insert membranes and manufacturing techniques (POP:7/27/2020 to 04/26/2021)
Ended Definitive Contract Awarded
- Contract number
- 75N95020C00016
- Awardee
-
Innovative Surface Technologies Inc. UEI HA96NDV2J3L5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $225,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541713 Research and Development in Nanotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- St Paul, MN 55114, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
About this award
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Innovative Surface Technologies Inc. (doing business as Isurtec), a small business manufacturer, for $225,000.00 under the Small Business Innovation Research (SBIR) Phase I program. The contract is for research and development of alternatives to commercially available cell culture insert membranes and manufacturing techniques, in support of the National Institutes of Health and Centers for Disease Control and Prevention's agency missions. This was a total small business set-aside contract, with the potential award being less than the $250,000 Phase I limit. The original solicitation was part of a broader SBIR/STTR funding opportunity covering a range of biomedical research topics for the NIH and CDC.
Quick answers
Who was awarded contract 75N95020C00016?
75N95020C00016 was awarded to Innovative Surface Technologies Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 27, 2020.
How much is contract 75N95020C00016 worth?
The government has obligated $225,000 on 75N95020C00016.
Which agency awarded contract 75N95020C00016?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020C00016, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95020C00016 competed?
The extent of competition for 75N95020C00016 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award